A study for a 28 year old man who takes Remicade - from FDA reports


Summary

3,958 males aged 28 (±5) who take the same drug are studied. This is a personalized study for a 28 year old male patient who has Ibs. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Oct, 13, 2017

3,958 males aged 28 (±5) who take Remicade are studied.


Number of reports submitted per year:

Remicade for a 28-year old man.

Information of the patient in this study:

  • Age: 28
  • Gender: male
  • Conditions: Ibs
  • Drugs taken:
    • Remicade (infliximab)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Rash: 152 (3.84% of males aged 28 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea
  • Rash in Ibs: 2 (2.06% of males aged 28 (±5) who have Ibs)

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  • infusion related reaction
  • breathing difficulty
  • fever
  • chest pain
  • rashes
  • nausea
  • skin blushing/flushing
  • chills
  • drug ineffective
  • joint pain
1 - 6 months:
  • drug ineffective
  • anaemia
  • leukopenia
  • hepatosplenic t-cell lymphoma
  • sepsis
  • thrombocytopenia
  • infusion related reaction
  • breathing difficulty
  • fever
  • tuberculosis
6 - 12 months:
  • drug ineffective
  • infusion related reaction
  • rashes
  • adverse event
  • large bowel resection
  • joint pain
  • chest pain
  • hypersensitivity
  • psoriasis
  • tuberculosis
1 - 2 years:
  • drug ineffective
  • joint pain
  • hospitalisation
  • fever
  • weight decreased
  • muscle spasms
  • diarrhea
  • nausea
  • breathing difficulty
  • headache
2 - 5 years:
  • infusion related reaction
  • drug ineffective
  • general physical health deterioration
  • back pain
  • chest pain
  • colon cancer
  • colitis
  • arrhythmias
  • diarrhea
  • rectal cancer
5 - 10 years:
  • hodgkin's lymphoma
  • non-hodgkin's lymphoma
  • chronic myeloid leukaemia
  • sleep apnea syndrome
  • postoperative wound infection
  • breathing difficulty
  • rashes
  • anorectal abscess
  • lymphoma
  • intestinal anastomosis complication
10+ years:
  • drug effect decreased
  • testis cancer
  • spinal fracture
  • ankylosing spondylitis
  • infusion site reaction
  • mycosis fungoides
  • breathing difficulty
  • histoplasmosis disseminated
  • dermatitis exfoliative
  • cough
not specified:
  • infusion related reaction
  • fever
  • drug ineffective
  • breathing difficulty
  • diarrhea
  • nausea
  • abdominal pain
  • chest pain
  • rashes
  • nausea and vomiting

Top conditions involved for these people *:

  • Ankylosing Spondylitis (394 people, 9.95%)
  • Psoriasis (137 people, 3.46%)
  • Psoriatic Arthropathy (87 people, 2.20%)
  • Preventive Health Care (55 people, 1.39%)
  • Pain (55 people, 1.39%)

Top co-used drugs for these people *:

  • Methotrexate (302 people, 7.63%)
  • Imuran (285 people, 7.20%)
  • Prednisone (252 people, 6.37%)
  • Azathioprine (221 people, 5.58%)
  • Pentasa (216 people, 5.46%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

  • Ibs (irritable bowel syndrome -chronic abdominal pain, discomfort, bloating) can be treated by Bentyl, Dicyclomine hydrochloride, Amitiza, Mebeverine hydrochloride, Linzess (latest reports from 25,212 Ibs patients)

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Ibs, Remicade, Rash

You may be interested in these reviews

More reviews for: Ibs, Remicade, Rash